The HDC platform doesn't seem to have any value yet in the eyes of the market. The large number of drug products that are being patented by SNTA should eventually hold huge value. Whenever a partnership or other deal with just one of the HDC platform drugs occurs, the value of SNTA will just skyrocket. One partnership with the potential for 400 others will open eyes of the analysts and move the share price of SNTA tremendously. Holding long in SNTA should one day prove to be a very lucrative move...it will take some time but when it happens...it will be phenomenal.